Section 1: Legislation - Medsafe
trial should be directed to Medsafe and will be considered on a case-by-case basis. A study using a xenotransplantation procedure is not a clinical trial that is
Download Section 1: Legislation - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzTreatment of recurrent, platinum-resistant disease: 10 mg/kg body weight given once every 2 weeks when administered in combination with one of …
Madopar (levodopa) Data Sheet (DS) - Medsafe
medsafe.govt.nzMADOPAR 160202 1 Data Sheet MADOPAR® Levodopa + benserazide Capsules 62.5, 125 and 250; dispersible tablet 62.5; HBS modified-release capsule 125
Section 1: Legislation relating to the labelling - …
medsafe.govt.nzPart 5, Ed 1.6 Page 2 of 18 . Section 1: Legislation relating to the labelling of medicines and related products Section summary This section lists the legislation regulating the labelling of medicines and related products.
NEW ZEALAND DATA SHEET VERMOX® - …
medsafe.govt.nzNEW ZEALAND DATA SHEET VERMOX® Vermox® Page 2 of 7 For control of enterobiasis Adults and children 2-12 years: 1 Vermox tablet (100 mg) or 5 mL of suspension (100 mg) is given.
Guideline on the Regulation of Therapeutic …
medsafe.govt.nzGuideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0
Clonazepam: oral drops (2.5 mg/ml); injection (1 mg).
medsafe.govt.nz2. you have severe and chronic lung disease 3. you have severe liver disease 4. you have an addiction to drugs or alcohol 5. the package is torn or shows signs of tampering
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzNEW ZEALAND DATA SHEET 5 Hypnovel 170717 Medical history of alcohol or drug abuse Hypnovel should be avoided in patients with a medical history of alcohol or drug abuse.
SCHEDULE OF FEES (effective from 1 July 2018)
medsafe.govt.nzPage 1 of 10. SCHEDULE OF FEES (effective from 1 July 2018) • All fees listed are GST inclusive. • More detailed descriptions of the type of application or change to which a fee applies can be
Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets
medsafe.govt.nz1 Nortriptyline NRIM 09052013 NEW ZEALAND DATA SHEET Nortriptyline NRIM . Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets . This product may not be interchangeable with similar products on the New Zealand market
2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3 ...
medsafe.govt.nz1. PRODUCT NAME LOSARTAN ACTAVIS (Losartan Potassium 12.5mg, 25mg, 50mg and 100mg Tablets) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains: 12.5 mg losartan potassium 25 mg losartan potassium 50 mg losartan potassium 100mg losartan potassium . For the full list of excipients, see section 6.1. 3. …
Related documents
SCI에대한오해 1.SCI와JCR의수록저널리스트불일치
library.samsunghospital.com1 sci에대한오해 1.sci와jcr의수록저널리스트불일치 jcr은sci에수록되어있는저널을중심으로인용정보를가공하지만수록저널이반드시일치하
Genetics and - Nuffield Bioethics
nuffieldbioethics.orgGenetics and human behaviour: the ethical context PRELIMS 13657 17/9/02 9:20 am Page i
Association Bulletin #16-05 - AABB
www.aabb.orgAssociation Bulletin #16-05 Date: March 17, 2016 To: AABB Members From: Donna Regan, MT(ASCP)SBB – President Miriam A. Markowitz – Chief Executive Officer Re: Changes to the 30th edition of Standards for Blood Banks and Transfusion Services
Full-Length Donor History Questionnaire (DHQ)
www.aabb.orgFull-Length Donor History Questionnaire (DHQ) Yes No Are you 1. Feeling healthy and well today? 2. Currently taking an antibiotic? 3.
SUPPLEMENT 3 VOL 9 - KDIGO
www.kdigo.orgSUPPLEMENT 3• VOL 9• 2009 American Journal of Transplantation • Volume 9 • Supplement 3 • November 2009 • PP. 1–156 ajt_9_S3-cover 10/8/09 17:16 Page 1
Comprehensive Placental Tissue Matrix & Amniotic
www.wmtemedia.comAdvantages of Amniotic & Placental Tissue MODULATE CORRECT TISSUE RECONSTRUCTION The placental Extracellular Matrix (ECM) modulates correct tissue